AbbVie Ev To Operating Cash Flow from 2010 to 2024

ABBV Stock  USD 183.08  1.94  1.07%   
AbbVie EV To Operating Cash Flow yearly trend continues to be fairly stable with very little volatility. EV To Operating Cash Flow will likely drop to 11.98 in 2024. EV To Operating Cash Flow is a valuation metric comparing AbbVie's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows. View All Fundamentals
 
EV To Operating Cash Flow  
First Reported
2010-12-31
Previous Quarter
14.03555147
Current Value
11.98
Quarterly Volatility
5.30146101
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.1 B, Interest Expense of 1.1 B or Selling General Administrative of 7.8 B, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0289 or PTB Ratio of 17.2. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Ev To Operating Cash Flow Growth Pattern

Below is the plot of the Ev To Operating Cash Flow of AbbVie Inc over the last few years. It is a valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows. AbbVie's EV To Operating Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
Ev To Operating Cash Flow10 Years Trend
Very volatile
   Ev To Operating Cash Flow   
       Timeline  

AbbVie Ev To Operating Cash Flow Regression Statistics

Arithmetic Mean14.78
Geometric Mean14.11
Coefficient Of Variation35.88
Mean Deviation3.37
Median13.64
Standard Deviation5.30
Sample Variance28.11
Range22.2207
R-Value(0.04)
Mean Square Error30.21
R-Squared0
Significance0.87
Slope(0.05)
Total Sum of Squares393.48

AbbVie Ev To Operating Cash Flow History

2024 11.98
2023 14.04
2022 13.64
2021 13.46
2020 14.57
2019 11.85
2018 13.04

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Ev To Operating Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EV To Operating Cash Flow 14.04  11.98 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.